Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial)

被引：21

作者：

Oparil, Suzanne ^{[1
]}

Lewis, Cora E. ^{[2
]}

机构：

[1] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Vasc Biol & Hypertens Program, Birmingham, AL 35294 USA

[2] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA

来源：

CIRCULATION | 2016年 / 134卷 / 18期

关键词：

D O I：

10.1161/CIRCULATIONAHA.116.023263

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1308 / 1310

页数：3

共 27 条

[1] Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? An Antagonist View From the HOPE-3 Trial (Heart Outcomes Evaluation-3)
Lonn, Eva M.
Yusuf, Salim
[J]. CIRCULATION, 2016, 134 (18) : 1311 - 1313
[2] Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT)
Wang, Katherine M.
Stedman, Margaret R.
Chertow, Glenn M.
Chang, Tara, I
[J]. HYPERTENSION, 2020, 76 (06) : 1725 - 1733
[3] Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension SPRINT (Systolic Blood Pressure Intervention Trial)
Soliman, Elsayed Z.
Ambrosius, Walter T.
Cushman, William C.
Zhang, Zhu-ming
Bates, Jeffrey T.
Neyra, Javier A.
Carson, Thaddeus Y.
Tamariz, Leonardo
Ghazi, Lama
Cho, Monique E.
Shapiro, Brian P.
He, Jiang
Fine, Lawrence J.
Lewis, Cora E.
[J]. CIRCULATION, 2017, 136 (05) : 440 - +
[4] Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT)
Zang, Jiabin
Liang, Jianwen
Zhuang, Xiaodong
Zhang, Shaozhao
Liao, Xinxue
Wu, Guifu
[J]. JOURNAL OF HUMAN HYPERTENSION, 2022, 36 (01) : 86 - 94
[5] Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT)
Jiabin Zang
Jianwen Liang
Xiaodong Zhuang
Shaozhao Zhang
Xinxue Liao
Guifu Wu
[J]. Journal of Human Hypertension, 2022, 36 : 86 - 94
[6] EFFECT OF INTENSIVE BLOOD PRESSURE TREATMENT ACCORDING TO BASELINE FRAMINGHAM RISK SCORE: RESULTS FROM SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT)
Zhuang, Xiaodong
Sun, Xiuting
Zhou, Huimin
Guo, Yue
Liao, Xinxue
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1917 - 1917
[7] Sex Differences of Patients With Systemic Hypertension (From the Analysis of the Systolic Blood Pressure Intervention Trial [SPRINT])
Ochoa-Jimenez, Roberto
Viquez-Beita, Karolina
Daluwatte, Chathuri
Zusterzeel, Robbert
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (06): : 985 - 993
[8] Comparison of Frequency of Atherosclerotic Cardiovascular and Safety Events With Systolic Blood Pressure <120 mm Hg Versus 135-139 mm Hg in a Systolic Blood Pressure Intervention Trial Primary Prevention Subgroup
Plante, Timothy B.
Juraschek, Stephen P.
Miller, Edgar R., III
Appel, Lawrence J.
Cushman, Mary
Littenberg, Benjamin
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (07): : 1185 - 1190
[9] Intensive Blood Pressure Management Preserves Functional Connectivity in Patients with Hypertension from the Systolic Blood Pressure Intervention Randomized Trial
Shah, C.
Srinivasan, D.
Erus, G.
Kurella Tamura, M.
Habes, M.
Detre, J. A.
Haley, W. E.
Lerner, A. J.
Wright, C. B.
Wright, J. T.
Oparil, S.
Kritchevsky, S. B.
Punzi, H. A.
Rastogi, A.
Malhotra, R.
Still, C. H.
Williamson, J. D.
Bryan, R. N.
Fan, Y.
Nasrallah, I. M.
[J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2023, 44 (05) : 582 - 588
[10] Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT Trial
Wang, Jue
Jiang, Chao
Li, Sitong
Wang, Zhiyan
Wang, Yufeng
Lai, Yiwei
Wang, Zhen
Lv, Wenhe
Bai, Yu
Yang, Zejun
Guo, Qi
Huang, Lihong
He, Liu
Guo, Xueyuan
Li, Songnan
Liu, Nian
Jiang, Chenxi
Tang, Ribo
Long, Deyong
Du, Xin
Sang, Caihua
Dong, Jianzeng
Ma, Changsheng
[J]. HYPERTENSION, 2023, 80 (11) : 2306 - 2314

← 1 2 3 →

Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to &lt;120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial)

Should Patients With Cardiovascular Risk Factors Receive Intensive Treatment of Hypertension to <120/80 mm Hg Target? A Protagonist View From the SPRINT Trial (Systolic Blood Pressure Intervention Trial)